Newsletter

So you want to sell your product to the federal marketplace: now what? The federal marketplace for healthcare and bioscience products is a large ecosystem. There are local, regional, and national systems, a variety of contract vehicles used, and plenty of federal stakeholders involved in the process. There is no single pathway that represents how … Read more

Jean Jiang currently studies gap junctions in cell membranes that facilitate cell-to-cell messages and ion travel. She has developed antibody therapeutics that target neuro-inflammatory injuries for reductions in local inflammation and scarring. This mechanism enables neurons to regenerate and improve recovery from spinal cord injury. She has also developed an antibody therapeutic for breast cancer … Read more

BioMedSA’s Board of Directors approved 7 new memberships in November, 2022: Community Labs, Medtech Reactor, Rochal Technologies, The Institute for Extracorporeal Life Support, Medwheels, Estancia del Norte Hotel and DoubleTree by Hilton San Antonio Airport, and Holly Stein Residential Realtor. Community Labs is a non-profit organization that was founded to keep San Antonio schools and … Read more

One of the biggest mistakes you can make while waiting for FDA approval is to think you can’t start working on your marketing strategy. This simply isn’t true. It’s true that a device that doesn’t yet have FDA marketing clearance is considered “investigational” and cannot be advertised or promoted. You definitely can’t start taking orders … Read more

Chiung-Yu Hung, Ph.D. studies pathogen interactions and is currently focused on developing treatments and a vaccine for Valley Fever (coccidiodes). This fungus lives in the soil in the southwestern US, Mexico, and parts of Central and South Amercia. An estimated 150,000 people are affected annually in the US with pulmonary issues as the primary result, … Read more

Bringing a new technology or invention to market is a long and arduous process. From conception to financing, from understanding the market and keeping tabs on competitors, the journey can be like threading a needle. Below are key questions that companies should answer and periodically update. Who are your competitors and how dominant are they? … Read more

Scott Jones, Ph.D., is the Senior VP and Chief Scientific Officer at BioBridge Global. His expertise involves donor screening, cell and gene therapy testing, and analytical develompent. He leads custom assay development projects, including the establishment of BioBridge Global’s CGMP cellular therapy testing services. He was the technical leader in the Community Labs launch during … Read more

BioMedSA’s Board of Directors approved 2 new memberships in October, 2022: betweenMD and TPKR Scientifics. betweenMD, inc. is a San Antonio based company which is developing solutions for individuals suffering from trauma induced chronic nightmares and PTSD.  betweenMD’s cloud-based technology platform and FDA approved wearable prescription digital therapeutics (pDTx) are supported by proprietary algorithms that … Read more

BioMedSA members with successful grant experience have volunteered to review SBIR proposals in order to increase the win rate for our community. The volunteers will have signed a confidentiality agreement prior to the review, but entrepreneurs are encouraged to redact any confidential information. Companies will need to plan for the anticipated review process times as … Read more

Using cryo-EM technology to flash-freeze proteins can generate clues to curing disease When physicians observe or hear of symptoms in their patients, they order CT scans, MRIs or other types of imaging analysis to understand the causes. Clinical imaging, however, does not illuminate the processes of life that occur deeper within, at the level of … Read more